1. Home
  2. GVP vs AYTU Comparison

GVP vs AYTU Comparison

Compare GVP & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GVP
  • AYTU
  • Stock Information
  • Founded
  • GVP 1994
  • AYTU N/A
  • Country
  • GVP United States
  • AYTU United States
  • Employees
  • GVP N/A
  • AYTU N/A
  • Industry
  • GVP Computer Software: Prepackaged Software
  • AYTU Biotechnology: Pharmaceutical Preparations
  • Sector
  • GVP Technology
  • AYTU Health Care
  • Exchange
  • GVP Nasdaq
  • AYTU Nasdaq
  • Market Cap
  • GVP 14.2M
  • AYTU 15.0M
  • IPO Year
  • GVP 1995
  • AYTU N/A
  • Fundamental
  • Price
  • GVP $4.09
  • AYTU $2.21
  • Analyst Decision
  • GVP Strong Buy
  • AYTU
  • Analyst Count
  • GVP 1
  • AYTU 0
  • Target Price
  • GVP $13.00
  • AYTU N/A
  • AVG Volume (30 Days)
  • GVP 44.8K
  • AYTU 30.7K
  • Earning Date
  • GVP 11-12-2024
  • AYTU 11-12-2024
  • Dividend Yield
  • GVP N/A
  • AYTU N/A
  • EPS Growth
  • GVP N/A
  • AYTU N/A
  • EPS
  • GVP N/A
  • AYTU N/A
  • Revenue
  • GVP $44,789,000.00
  • AYTU $81,002,000.00
  • Revenue This Year
  • GVP $29.76
  • AYTU N/A
  • Revenue Next Year
  • GVP $10.48
  • AYTU N/A
  • P/E Ratio
  • GVP N/A
  • AYTU N/A
  • Revenue Growth
  • GVP N/A
  • AYTU N/A
  • 52 Week Low
  • GVP $1.21
  • AYTU $2.20
  • 52 Week High
  • GVP $5.38
  • AYTU $3.50
  • Technical
  • Relative Strength Index (RSI)
  • GVP 59.81
  • AYTU 39.00
  • Support Level
  • GVP $4.02
  • AYTU $2.26
  • Resistance Level
  • GVP $4.05
  • AYTU $2.44
  • Average True Range (ATR)
  • GVP 0.04
  • AYTU 0.14
  • MACD
  • GVP -0.01
  • AYTU -0.02
  • Stochastic Oscillator
  • GVP 80.00
  • AYTU 2.03

About GVP GSE Systems Inc.

GSE Systems Inc is a company engaged in providing engineering, staffing, and simulation software to clients in the power and process industries. It also provides interactive computer-based tutorials and simulation software for the refining, chemical, and petrochemical industries. It functions through two segments: The engineering segment and the Workforce Solutions segment. Its geographical segments include the United States, Europe, and Asia, out of which the majority of the revenue is generated from the United States.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which it generates maximum revenue from the Rx segment.

Share on Social Networks: